Publications by authors named "Stephanie L Wu"
Background: While 2-4% of lung cancers possess alterations in BRAF, little is known about the immune responsiveness of these tumours.
Methods: Clinical and genomic data were collected from 5945 patients with lung cancers whose tumours underwent next-generation sequencing between 2015 and 2018. Patients were followed through 2020.